MELISSA MUHS: Open Payments
NPI 1457430357 · LA VISTA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 53 payments from 17 companies in 2025. Trend: 2023 $772 · 2024 $1,098 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $277 |
| ABBVIE INC. | 13 | $198 |
| Lilly USA, LLC | 6 | $93 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $88 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| PFIZER INC. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| LEO Pharma Inc. | 1 | $27 |
Products named: Ozempic, QULIPTA, Wegovy, GEMTESA, Kerendia, VRAYLAR, MOUNJARO, INSPIRE.
Industry payments across NE — which companies pay providers there.
